Zamicastat - Bial
Alternative Names: BIA-5-1058Latest Information Update: 28 Jul 2022
At a glance
- Originator Bial
- Developer BIAL
- Class Amines; Chromans; Fluorinated hydrocarbons; Heart failure therapies; Imidazoles; Small molecules; Thiones
- Mechanism of Action Dopamine beta-hydroxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Pulmonary arterial hypertension
- No development reported Heart failure
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for phase-I development in Heart-failure(In volunteers) in Portugal (PO, Tablet)
- 28 Jul 2022 No recent reports of development identified for phase-I development in Heart-failure(In volunteers) in United Kingdom (PO, Tablet)
- 28 Jul 2022 No recent reports of development identified for phase-I development in Pulmonary-arterial-hypertension(In volunteers) in Germany (PO, Tablet)